1504: IMMUNE CHECKPOINT INHIBITORS IN SEPSIS: A PHASE 1B TRIAL OF ANTI-PD-L1 (BMS-936559)No AbstractGrasela, DennisCritical care medicineHotchkiss RS, Colston E, Yende S et al. Immune checkpoint inhibitors in sepsis: a phase 1b trial of anti-PD-L1 (BMS- 936559). Crit. Care Med. ...
LyleHotchkiss RS, Colston E, Yende S et al. Immune checkpoint inhibitors in sepsis: a phase 1b trial of anti-PD-L1 (BMS- 936559). Crit. Care Med. 2018; 46(Suppl): 736. https://doi. org/(10.1097/01.ccm.0000529506.43290.de).